| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |